Metastatic signet-ring cell carcinoma of the urinary bladder: A novel management approach to a rare tumour

Neil Pugashetti; A. Stanley; N. Primo; Gandour Edwards Regina; A. Marc

doi:10.5489/cuaj.2447

Metastatic signet-ring cell carcinoma of the urinary bladder: A novel management approach to a rare tumour

Neil Pugashetti, A. Stanley, N. Primo, Gandour Edwards Regina, A. Marc

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

Primary signet-ring cell carcinoma (SRCC) of the urinary bladder, a variant of adenocarcinoma, is exceedingly rare and as a result no gold standard exists for its management. We report a case of primary SRCC of the bladder with recurrent metastases; we utilized an innovative diagnostic approach and the patient exhibited a treatment response to palliative FOLFOX-6 chemotherapy.

Original language	English (US)
Pages (from-to)	E204-E207
Journal	Journal of the Canadian Urological Association
Volume	9
Issue number	3-4APRIL
DOIs	https://doi.org/10.5489/cuaj.2447
State	Published - Apr 13 2015

Keywords

Bladder cancer
FOLFOX-6
Metastatic
Next generation sequencing
Signet-ring cell carcinoma

ASJC Scopus subject areas

Oncology
Urology

Access to Document

10.5489/cuaj.2447

Fingerprint Dive into the research topics of 'Metastatic signet-ring cell carcinoma of the urinary bladder: A novel management approach to a rare tumour'. Together they form a unique fingerprint.

Cite this

@article{a3597fb594c14ebb80ae210e262e578b,

title = "Metastatic signet-ring cell carcinoma of the urinary bladder: A novel management approach to a rare tumour",

abstract = "Primary signet-ring cell carcinoma (SRCC) of the urinary bladder, a variant of adenocarcinoma, is exceedingly rare and as a result no gold standard exists for its management. We report a case of primary SRCC of the bladder with recurrent metastases; we utilized an innovative diagnostic approach and the patient exhibited a treatment response to palliative FOLFOX-6 chemotherapy.",

keywords = "Bladder cancer, FOLFOX-6, Metastatic, Next generation sequencing, Signet-ring cell carcinoma",

author = "Neil Pugashetti and A. Stanley and N. Primo and Regina, {Gandour Edwards} and A. Marc",

year = "2015",

month = apr,

day = "13",

doi = "10.5489/cuaj.2447",

language = "English (US)",

volume = "9",

pages = "E204--E207",

journal = "Journal of the Canadian Urological Association",

issn = "1911-6470",

publisher = "Canadian Medical Association",

number = "3-4APRIL",

}

TY - JOUR

T1 - Metastatic signet-ring cell carcinoma of the urinary bladder

T2 - A novel management approach to a rare tumour

AU - Pugashetti, Neil

AU - Stanley, A.

AU - Primo, N.

AU - Regina, Gandour Edwards

AU - Marc, A.

PY - 2015/4/13

Y1 - 2015/4/13

N2 - Primary signet-ring cell carcinoma (SRCC) of the urinary bladder, a variant of adenocarcinoma, is exceedingly rare and as a result no gold standard exists for its management. We report a case of primary SRCC of the bladder with recurrent metastases; we utilized an innovative diagnostic approach and the patient exhibited a treatment response to palliative FOLFOX-6 chemotherapy.

AB - Primary signet-ring cell carcinoma (SRCC) of the urinary bladder, a variant of adenocarcinoma, is exceedingly rare and as a result no gold standard exists for its management. We report a case of primary SRCC of the bladder with recurrent metastases; we utilized an innovative diagnostic approach and the patient exhibited a treatment response to palliative FOLFOX-6 chemotherapy.

KW - Bladder cancer

KW - FOLFOX-6

KW - Metastatic

KW - Next generation sequencing

KW - Signet-ring cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=84928014346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928014346&partnerID=8YFLogxK

U2 - 10.5489/cuaj.2447

DO - 10.5489/cuaj.2447

M3 - Article

AN - SCOPUS:84928014346

VL - 9

SP - E204-E207

JO - Journal of the Canadian Urological Association

JF - Journal of the Canadian Urological Association

SN - 1911-6470

IS - 3-4APRIL

ER -